Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Revising the NIH/AHRQ/NIOSH Post-Submission Material Policy
(NOT-OD-23-106)
National Institutes of Health
General Notices
- Notice of Pre-Application Webinar for RFA-AG-24-009, Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)
(NOT-AG-23-018)
National Institute on Aging
- Notice to Extend the Response Date for NOT-AI-23-017, "Request for Information (RFI): Seeking Stakeholder Input on Enhancing Diversity, Equity, Inclusion, and Accessibility Across NIAID Extramural Activities"
(NOT-AI-23-041)
National Institute of Allergy and Infectious Diseases
- Notice of NCI Virtual Workshop to Engage Multi-Cancer Detection (MCD) Assay Developers
(NOT-CA-23-055)
National Cancer Institute
- Notice of Joint NIGMS/NSF Initiative to Support A Science of Science Approach to Analyzing and Innovating the Biomedical Research Enterprise (SoS:BIO)
(NOT-GM-23-038)
National Institute of General Medical Sciences
- Notice of Early Expiration of NOT-HD-22-043 "Notice of Special Interest ( NOSI ): Implementation Science to Advance Maternal Health and Maternal Health Equity for the IMPROVE initiative"
(NOT-HD-23-008)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notice of Changes to Funding Opportunities
- Notice of Participation of the National Institute of Allergy and Infectious Diseases (NIAID) in PAR-23-120, Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)
(NOT-AI-23-040)
National Institute of Allergy and Infectious Diseases
- Notice to Extend NCCIH's PAR-20-218, PAR-20-217, PAR-20-216, PAR-20-215, and PAR-20-219
(NOT-AT-24-003)
National Center for Complementary and Integrative Health
- Notice of Correction to Application Due Dates in PAR-22-049 "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)"
(NOT-CA-23-054)
National Cancer Institute
- Notice of Participation of the National Institute of Nursing Research (NINR) in PAR-23-122, "Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)"
(NOT-NR-23-010)
National Institute of Nursing Research
- Notice to Extend Parent R01/R03/R21 Parent Notices of Funding Opportunities
(NOT-OD-23-105)
National Institutes of Health
National Institute on Aging
Notices of Special Interest
- Notice of Special Interest (NOSI): Administrative Supplement for Collaborative Projects Supported by the NIAID RNCP and CCRP
(NOT-AI-23-037)
National Institute of Allergy and Infectious Diseases
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke
- Notice of Special Interest of NCCIH in PAR-22-097/098, "Global Brain and Nervous System Disorders Research Across the Lifespan (R01/R21 Clinical Trial Optional)
(NOT-AT-24-001)
National Center for Complementary and Integrative Health
- Notice of Special Interest (NOSI): Encouraging Womens Health Research within the NIDCD Mission Areas
(NOT-DC-23-006)
National Institute on Deafness and Other Communication Disorders
- Notice of Special Interest (NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health Disparities
(NOT-MD-23-008)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental and Craniofacial Research
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Office of Research on Women's Health
Funding Opportunities
- NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
(PAR-23-132)
National Institute of Dental and Craniofacial Research
- NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)
(PAR-23-133)
National Institute of Dental and Craniofacial Research
- Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)
(PAR-23-148)
National Institute of Allergy and Infectious Diseases
- Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)
(PAR-23-152)
National Cancer Institute
- Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)
(PAR-23-153)
National Cancer Institute
- Animal Models for Hepatitis B and C (R01 Clinical Trial Not Allowed)
(RFA-AI-23-022)
National Institute of Allergy and Infectious Diseases
- Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional)
(RFA-CA-23-023)
National Cancer Institute
- BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required)
(RFA-DC-24-001)
National Institute on Deafness and Other Communication Disorders
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
- BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
(RFA-MH-23-110)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
- BRAIN Initiative: Brain Behavior Quantification and Synchronization Data Coordination and Artificial Intelligence Center (U24 Clinical Trial Optional)
(RFA-MH-23-130)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
- Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
(RFA-MH-23-260)
National Institute of Mental Health
Office of Disease Prevention
- Developing Measures to Advance Access and Quality in Global Mental Health Services (R34 Clinical Trial Not Allowed)
(RFA-MH-23-300)
National Institute of Mental Health
- Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional)
(RFA-NS-23-021)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
National Institute of Mental Health
- Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional)
(RFA-NS-23-022)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
National Institute of Mental Health
- Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional)
(RFA-OD-23-015)
Office of Disease Prevention
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute on Minority Health and Health Disparities
Office of Research on Women's Health
- NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
(RFA-RM-23-005)
Office of Strategic Coordination (Common Fund)
- NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
(RFA-RM-23-006)
Office of Strategic Coordination (Common Fund)
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail)(link sends e-mail) or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail)(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail)(link sends e-mail).